Decreased activity of clotting factor V during ALL consolidation treatment with mercaptopurine in a child.
Vignand
Claire
C
Couillault
Gérard
G
Jolimoy
Genevieve
G
Dutrillaux
Fabienne
F
Sgro
Catherine
C
D002648:Child; D005165:Factor V / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood* / Q000188:drug therapy; D013997:Time Factors
D005165:Factor V; D015122:Mercaptopurine